New research presented at the European Society of Cardiology (ESC) Congress 2024 is making the case that clinicians should consider cancer as a risk factor for subclinical atherosclerosis.

Presented by Sara Diaz Saravia, MD, of Mount Sinai Morningside, the study, which was a case-control study of nearly 4000 females in a primary prevention chart, concluded history of cancer acted as an independent and significant predictor for subclinical atherosclerosis.

To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

Source: MDMag

https://www.hcplive.com/view/in-women-history-of-cancer-linked-to-subclinical-atherosclerosis